These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20585109)

  • 1. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
    Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
    Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
    Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis.
    Bian Z; Cai J; Shen DF; Chen L; Yan L; Tang Q; Li H
    J Cell Mol Med; 2009 Jul; 13(7):1302-13. PubMed ID: 19413895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
    J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
    Cai J; Yi FF; Yang L; Shen DF; Yang Q; Li A; Ghosh AK; Bian ZY; Yan L; Tang QZ; Li H; Yang XC
    Hypertension; 2009 Mar; 53(3):539-48. PubMed ID: 19204184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20 is dynamically regulated in the heart and inhibits the hypertrophic response.
    Cook SA; Novikov MS; Ahn Y; Matsui T; Rosenzweig A
    Circulation; 2003 Aug; 108(6):664-7. PubMed ID: 12900338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice.
    Huang Y; Wu L; Wu J; Li Y; Hou L
    Mol Cell Biochem; 2014 Dec; 397(1-2):87-95. PubMed ID: 25087120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
    Cai J; Yi FF; Bian ZY; Shen DF; Yang L; Yan L; Tang QZ; Yang XC; Li H
    J Cell Mol Med; 2009 May; 13(5):909-25. PubMed ID: 19413885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.
    Hui X; Hu F; Liu J; Li C; Yang Y; Shu S; Liu P; Wang F; Li S
    J Mol Cell Cardiol; 2021 Feb; 151():31-43. PubMed ID: 32971071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
    Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
    Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
    J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
    Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
    Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
    Chen Y; He T; Zhang Z; Zhang J
    Pharmacology; 2021; 106(11-12):667-681. PubMed ID: 34518478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
    Deng W; Jiang D; Fang Y; Zhou H; Cheng Z; Lin Y; Zhang R; Zhang J; Pu P; Liu Y; Bian Z; Tang Q
    J Mol Histol; 2013 Oct; 44(5):575-85. PubMed ID: 23719775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
    Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
    Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G protein signaling 3 protects against cardiac hypertrophy in mice.
    Liu Y; Huang H; Zhang Y; Zhu XY; Zhang R; Guan LH; Tang Q; Jiang H; Huang C
    J Cell Biochem; 2014 May; 115(5):977-86. PubMed ID: 24375609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.